Vabysmo 6 MG/0.05 ML syringe 0.05ML

Ended Awarded

Contract number
SPE2DR26FRRL4
Awardee
Awarding agency
Obligated
$14,703

Award facts

Contract value 100% obligated
$14,702.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on January 12, 2026, with a ceiling value of $14,702.80 for VABYSMO 6 mg/0.05 mL syringes under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is firm fixed price with an ultimate completion date of February 3, 2026. Place of performance is Park Ridge, Illinois, with worldwide delivery to Department of Defense military healthcare facilities.

Quick answers

Who was awarded contract SPE2DR26FRRL4?

SPE2DR26FRRL4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 12, 2026.

How much is contract SPE2DR26FRRL4 worth?

The government has obligated $14,703 on SPE2DR26FRRL4.

Is contract SPE2DR26FRRL4 an order under another contract?

Yes. SPE2DR26FRRL4 is a delivery order under SPE2DR25D9238, an indefinite delivery contract.

Was contract SPE2DR26FRRL4 competed?

The extent of competition for SPE2DR26FRRL4 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award